Nanomedicine and medicinal plants: Emerging symbiosis in managing lung diseases and associated infections
- PMID: 36483911
- PMCID: PMC9727245
- DOI: 10.17179/excli2022-5376
Nanomedicine and medicinal plants: Emerging symbiosis in managing lung diseases and associated infections
Similar articles
-
Arbuscular mycorrhizal symbiosis and active ingredients of medicinal plants: current research status and prospectives.Mycorrhiza. 2013 May;23(4):253-65. doi: 10.1007/s00572-013-0484-0. Epub 2013 Feb 17. Mycorrhiza. 2013. PMID: 23417725 Review.
-
[Discussion on appraisal methods and key technologies of arbuscular mycorrhizal fungi and medicinal plant symbiosis system].Zhongguo Zhong Yao Za Zhi. 2011 Nov;36(21):3051-6. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22308700 Chinese.
-
Arbuscular mycorrhizal symbiosis for sustainable cultivation of Chinese medicinal plants: a promising research direction.Am J Chin Med. 2013;41(6):1199-221. doi: 10.1142/S0192415X1350081X. Am J Chin Med. 2013. PMID: 24228596
-
Antiviral potentials of medicinal plants.Virus Res. 2008 Feb;131(2):111-20. doi: 10.1016/j.virusres.2007.09.008. Epub 2007 Nov 5. Virus Res. 2008. PMID: 17981353 Free PMC article. Review.
-
Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.Pediatr Pulmonol. 2013 Nov;48(11):1098-111. doi: 10.1002/ppul.22657. Epub 2013 Sep 2. Pediatr Pulmonol. 2013. PMID: 23997035
Cited by
-
Fisetin-loaded nanoemulsion ameliorates lung cancer pathogenesis via downregulating cathepsin-B, galectin-3 and enolase in an in vitro setting.EXCLI J. 2024 Oct 14;23:1238-1244. doi: 10.17179/excli2024-7583. eCollection 2024. EXCLI J. 2024. PMID: 39574963 Free PMC article. No abstract available.
-
Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease.Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2793-2833. doi: 10.1007/s00210-023-02830-w. Epub 2023 Nov 22. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37991539 Review.
-
Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects.Phytother Res. 2024 Dec;38(12):5840-5872. doi: 10.1002/ptr.8334. Epub 2024 Oct 9. Phytother Res. 2024. PMID: 39385504 Free PMC article. Review.
-
Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):343-356. doi: 10.1007/s00210-023-02603-5. Epub 2023 Jul 13. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37439806 Free PMC article.
References
-
- Chan Y, Mehta M, Paudel KR, Madheswaran T, Panneerselvam J, Gupta G, et al. Versatility of liquid crystalline nanoparticles in inflammatory lung diseases. Nanomedicine (Lond) 2021;16:1545–1548. - PubMed
-
- Chan Y, Raju Allam VSR, Paudel KR, Singh SK, Gulati M, Dhanasekaran M, et al. Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases. Crit Rev Food Sci Nutr. 2021;epub ahead of print:1–31. - PubMed
-
- Chin LH, Hon CM, Chellappan DK, Chellian J, Madheswaran T, Zeeshan F, et al. Molecular mechanisms of action of naringenin in chronic airway diseases. Eur J Pharmacol. 2020;879:173139. - PubMed
-
- de Oliveira MTP, de Sa Coutinho D, Tenorio de Souza E, Staniscuaski Guterres S, Pohlmann AR, Silva PMR, et al. Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways. Int J Nanomedicine. 2019;14:5215–5228. - PMC - PubMed
-
- Devkota HP, Paudel KR, Jha NK, Gupta PK, Singh SK, Chellappan DK, et al. Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases. Nanomedicine (Lond) 2021;16:2407–2410. - PubMed
LinkOut - more resources
Full Text Sources